Job Description
3T Biosciences is solving a major bottleneck in the field of immunotherapy – identifying novel targets that can be used to generate therapies to treat cancer in broad patient populations. We are developing transformative T cell receptor therapies for cancer, focusing on solid tumors and other immune-related diseases. Our proprietary experimental and computational technology initially developed at Stanford University with over 20 years of research allows us to identify novel T cell receptor targets as well as to predict potential clinical toxicities to enable the development of safe and effective therapies.
Culture:
We’re committed to making a difference for patients. Our focused, creative, and ambitious team makes 3T Biosciences the perfect engine to drive therapeutic solutions to reality. We’re looking for enthusiastic and self-motivated individuals to bring their talents to a fast-paced environment.
Your Typical Responsibilities:
- Design and execution of critical experiments for the discovery of therapeutic TCRs
- Cellular engineering including lentiviral transduction and gene editing
- Developing T cell activation, tumor cell killing, antigen processing, and off-target toxicity assays for therapeutic discovery and development
- Interfacing with a team of computational and experimental biologists to aid in experimental and computational designs
Required Qualifications:
- Doctoral (PhD) degree or equivalent
- 2+ years of industry experience related to primary immune cell research
- Experience working with human tumor specimens, blood samples
- Experience in molecular biology techniques and cellular immunology techniques (cell killing assays, flow cytometry, cytokine secretion assays, antigen processing assays, lentiviral transduction)
- Knowledge in immunology (T cell biology) and oncology (tumor models, cancer types and lines of therapy)
- Self-motivated and a proactive thinker – can work independently and in teams
- Excellent written and communication skills presenting scientific data
Preferred Qualifications:
- Knowledge and/or experience with adoptive T cell therapies
- Knowledge and/or experience with lentiviral transduction
- Knowledge and/or experience with synthetic biology techniques
